Estrogen Attenuates the Inhibition of Nitric Oxide Synthase Type 3 Induced by Advanced Glycation End-Products
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To investigate the effects of advanced glycation end-products(AGE) on endothelial nitric oxide synthase type 3(NOS-3) and whether estrogen may influence such effects,then to discover the underlying mechanisms. Methods Cultured human umbilical endothelial cells were administered with different concentrations of AGE and/or estrogen,then western blotting was applied to detect the variation of NOS-3 and Akt protein expression. Results After the administration of AGE(50,100 and 200 mg/L) for 4 h,endothelial cells exhibited lower protein expression of NOS-3 and Akt;after administration of estrogen(10-9,10-8 and 10-7 mol/L),endothelial cells presented higher protein expression of NOS-3 and Akt.Furthermore,with the pretreatment of estrogen(10-8mol/L),the inhibition on NOS-3 protein expression by AGE(100 mg/L) was remarkably ameliorated.As for protein kinase Akt,it demonstrated similar changes. Conclusions AGE could notably suppress the protein expression of NOS-3 in endothelial cells,while estrogen could effectively ameliorate this suppression.The protective effects of estrogen might relate to its positive regulation on the up-stream signaling protein kinase Akt.

    Reference
    Related
    Cited by
Get Citation

HAN Yi, XIE Li-Ping, LIU Zhen, JI Yong, and LIU Nai-Feng. Estrogen Attenuates the Inhibition of Nitric Oxide Synthase Type 3 Induced by Advanced Glycation End-Products[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2009,17(11):889-892.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 16,2009
  • Revised:October 12,2009
Article QR Code